# Real-World Study of PADN for the Treatment of PAH

> **NCT07039604** · — · RECRUITING · sponsor: **Pulnovo Medical (Wuxi) Co., Ltd.** · enrollment: 200 (estimated)

## Conditions studied

- Pulmonary Hypertension
- Hypertension, Pulmonary Arterial

## Interventions

- **DEVICE:** Enhancor™ Radiofrequency Catheter, Pulnovo Medical (Wuxi) CO., Ltd., Wuxi, Jiangsu, China

## Key facts

- **NCT ID:** NCT07039604
- **Lead sponsor:** Pulnovo Medical (Wuxi) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-19
- **Primary completion:** 2028-12-30
- **Final completion:** 2028-12-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07039604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07039604, "Real-World Study of PADN for the Treatment of PAH". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07039604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*